BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 28621240)

  • 1. IL-36α suppresses proliferation of ovarian cancer cells.
    Chang L; Guo R; Yuan Z
    Tumour Biol; 2017 Jun; 39(6):1010428317706918. PubMed ID: 28621240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis.
    Li Y; Xiao M; Guo F
    Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of interleukin-36α correlates with poor prognosis in hepatocellular carcinoma.
    Pan QZ; Pan K; Zhao JJ; Chen JG; Li JJ; Lv L; Wang DD; Zheng HX; Jiang SS; Zhang XF; Xia JC
    Cancer Immunol Immunother; 2013 Nov; 62(11):1675-85. PubMed ID: 24061617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
    Li L; Duan Z; Yu J; Dang HX
    Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-36α inhibits colorectal cancer metastasis by enhancing the infiltration and activity of CD8
    Wei X; Yao Y; Wang X; Sun J; Zhao W; Qiu L; Zhai W; Qi Y; Gao Y; Wu Y
    Int Immunopharmacol; 2021 Nov; 100():108152. PubMed ID: 34555640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
    Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
    Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-36α suppresses growth of non-small cell lung cancer in vitro by reducing angiogenesis.
    Xie X; Hu H; He J; Liu Y; Guo F; Luo F; Jiang M; Wang L
    FEBS Open Bio; 2021 May; 11(5):1353-1363. PubMed ID: 33713575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Par3 polarity protein correlates with poor prognosis in ovarian cancer.
    Nakamura H; Nagasaka K; Kawana K; Taguchi A; Uehara Y; Yoshida M; Sato M; Nishida H; Fujimoto A; Inoue T; Adachi K; Nagamatsu T; Arimoto T; Oda K; Osuga Y; Fujii T
    BMC Cancer; 2016 Nov; 16(1):897. PubMed ID: 27855669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
    Wan J; Shi F; Xu Z; Zhao M
    Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients.
    Wang ZS; Cong ZJ; Luo Y; Mu YF; Qin SL; Zhong M; Chen JJ
    Int J Clin Exp Pathol; 2014; 7(11):8077-81. PubMed ID: 25550854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
    Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
    J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2016 Jan; 48(1):181-90. PubMed ID: 26575700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNAI1 overexpression induces stemness and promotes ovarian cancer cell invasion and metastasis.
    Lu ZY; Dong R; Li D; Li WB; Xu FQ; Geng Y; Zhang YS
    Oncol Rep; 2012 May; 27(5):1587-91. PubMed ID: 22344746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway.
    Gao J; Liu M; Zou Y; Mao M; Shen T; Zhang C; Song S; Sun M; Zhang S; Wang B; Zhu D; Li P
    Oncol Rep; 2015 Dec; 34(6):3212-21. PubMed ID: 26503132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein.
    Qi X; Du L; Chen X; Chen L; Yi T; Chen X; Wen Y; Wei Y; Zhao X
    Int J Oncol; 2016 Jul; 49(1):123-32. PubMed ID: 27211072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-36α exerts pro-inflammatory effects in the lungs of mice.
    Ramadas RA; Ewart SL; Iwakura Y; Medoff BD; LeVine AM
    PLoS One; 2012; 7(9):e45784. PubMed ID: 23029241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose glucocorticoids suppresses ovarian tumor growth and metastasis in an immunocompetent syngeneic mouse model.
    Lin KT; Sun SP; Wu JI; Wang LH
    PLoS One; 2017; 12(6):e0178937. PubMed ID: 28591224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of microRNA-497 suppresses cell proliferation and induces apoptosis through targeting paired box 2 in human ovarian cancer.
    Lin Z; Zhao J; Wang X; Zhu X; Gong L
    Oncol Rep; 2016 Oct; 36(4):2101-7. PubMed ID: 27513319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.